Stock Market & Financial Investment News

News Breaks February 27, 2013 07:33 EDT VPHM ViroPharma sees FY13 worldwide net product sales $450M-$475M Sees FY13 net North American sales $390M-$400M. Sees FY13 R&D, SG&A expenses $240M-$260M News For VPHM From The Last 14 Days Check below for free stories on VPHM the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for VPHM Sign up for a free trial to see the rest of the stories you've been missing.